Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1992-04-21
1993-10-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514811, 514813, 514909, 514910, 564304, 564347, A61K 31165
Patent
active
052505723
ABSTRACT:
The present invention provides (R)-norfluoxetine and pharmaceutically acceptable salts thereof capable of selectively occupying 5HT.sub.1c receptors.
REFERENCES:
patent: 4018895 (1977-04-01), Molloy et al.
patent: 4194009 (1980-05-01), Molloy et al.
patent: 4313896 (1982-02-01), Molloy et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4584404 (1986-04-01), Molloy et al.
patent: 4626549 (1986-12-01), Molloy et al.
Robertson et al., J. Med. Chem., 31, 1412 (1988).
Wong et al., Drug Development Research, 6, 397 (1985).
Fuller et al., Pharmacology Biochemistry and Behavior, 24, 281 (1986).
Nash et al., Clin. Chem., 28(10), 2100 (1982).
Aronoff et al., Clin. Pharmacol. Ther., 36(1), 138 (1984).
Wong, et al., Biochemical Pharmacology, 32(7), 1287 (1983).
Hall, et al., Acta pharmacol. et toxicol., 54, 379 (1984).
Thomas, et al., Psychopharmacology, 93, 193 (1987).
Robertson David W.
Wong David T.
Conrad Robert A.
Eli Lilly and Company
Jones Joseph A.
Raymond Richard L.
Whitaker Leroy
LandOfFree
(R)-norfluoxetine in method for occupying serotonin IC receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (R)-norfluoxetine in method for occupying serotonin IC receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (R)-norfluoxetine in method for occupying serotonin IC receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1004351